Business Description
Sino Biological Inc
No. 18 Kechuang 10th Street, Room 306, Building 9, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176
Compare
Compare
Traded in other countries / regions
301047.China
Description
Sino Biological Inc is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 117.18 | |||||
| Equity-to-Asset | 0.98 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.09 | |||||
| Interest Coverage | 164.14 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 64.06 | |||||
| Beneish M-Score | -2 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y Total Revenue Growth Rate Industry Rank | -5.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.12 | |||||
| 9-Day RSI | 40.13 | |||||
| 14-Day RSI | 40.34 | |||||
| 6-1 Month Momentum % | -26.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 66.59 | |||||
| Quick Ratio | 66.22 | |||||
| Cash Ratio | 64.28 | |||||
| Days Inventory | 148.43 | |||||
| Days Sales Outstanding | 89.21 | |||||
| Days Payable | 86.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 8.7 | |||||
| Forward Dividend Yield % | 8.7 | |||||
| 5-Year Yield-on-Cost % | 8.7 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 89.48 | |||||
| Operating Margin % | 64.5 | |||||
| Net Margin % | 74.55 | |||||
| ROE % | 8.53 | |||||
| ROA % | 8.34 | |||||
| ROIC % | 106.76 | |||||
| ROC (Joel Greenblatt) % | 212.61 | |||||
| ROCE % | 9.8 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 26.73 | |||||
| Forward PE Ratio | 38.06 | |||||
| PE Ratio without NRI | 26.73 | |||||
| PS Ratio | 17.76 | |||||
| PB Ratio | 2.38 | |||||
| Price-to-Tangible-Book | 2.37 | |||||
| Price-to-Free-Cash-Flow | 44.56 | |||||
| Price-to-Operating-Cash-Flow | 33.19 | |||||
| EV-to-EBIT | 16.49 | |||||
| EV-to-Forward-EBIT | 35.19 | |||||
| EV-to-EBITDA | 16.49 | |||||
| EV-to-Forward-EBITDA | 33.83 | |||||
| EV-to-Revenue | 14.23 | |||||
| EV-to-Forward-Revenue | 16.24 | |||||
| EV-to-FCF | 33.11 | |||||
| Price-to-Graham-Number | 1.68 | |||||
| Price-to-Net-Current-Asset-Value | 2.47 | |||||
| Price-to-Net-Cash | 2.56 | |||||
| Earnings Yield (Greenblatt) % | 6.06 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 629.877 | ||
| EPS (TTM) (¥) | 4.314 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 40.34 | ||
| 14-Day ATR (¥) | 3.775454 | ||
| 20-Day SMA (¥) | 118.1615 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (¥) | 105.85 - 368.094736 | ||
| Shares Outstanding (Mil) | 129.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sino Biological Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||